David C. Marek

Chief Executive Officer bei MYOVANT SCIENCES LTD.

59 Jahre

Health Technology

Technology Services

Consumer Services

Aktive Positionen von David C. Marek

Unternehmen	Position	Beginn	Ende
MYOVANT SCIENCES LTD.	Chief Executive Officer	04.01.2021	-
MYOVANT SCIENCES LTD.	Director/Board Member	04.01.2021	10.03.2023

Karriereverlauf von David C. Marek

Ehemalige bekannte Positionen von David C. Marek

Unternehmen	Position	Beginn	Ende
Myovant Sciences, Inc. Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.	Director/Board Member	04.01.2021	01.06.2023
	Chief Executive Officer	04.01.2021	01.06.2023
AXSOME THERAPEUTICS, INC.	Corporate Officer/Principal	01.08.2019	31.12.2020
AMGEN INC.	Corporate Officer/Principal	-	01.06.2019
AMGEN INC.	Sales & Marketing	01.06.2015	01.06.2017
WEBMD HEALTH CORP.	Corporate Officer/Principal	04.09.2012	01.01.2014
Saatchi & Saatchi Healthcare Advertising Saatchi & Saatchi Healthcare Advertising Advertising/Marketing ServicesCommercial Services Part of Publicis Healthcare Communications Group, Inc., Saatchi & Saatchi Healthcare Advertising provides advertising services.	Corporate Officer/Principal	01.03.2000	01.01.2011

Ausbildung von David C. Marek

Washington State University

Undergraduate Degree

Statistik

International

Vereinigte Staaten	7
Vereinigtes Königreich	2

Operativ

Corporate Officer/Principal	4
Director/Board Member	2
Chief Executive Officer	2

Sektoral

Health Technology	5
Technology Services	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	2
AMGEN INC.	Health Technology
AXSOME THERAPEUTICS, INC.	Health Technology

Private Unternehmen	4
WebMD Health Corp. WebMD Health Corp. Internet Software/ServicesTechnology Services WebMD Health Corp. engages in the provision of health information services. It serves physicians, health care professionals, employers, and health plans through public and private online portals, mobile platforms, and health-focused publications. The company is headquartered in New York, NY.	Technology Services
Saatchi & Saatchi Healthcare Advertising Saatchi & Saatchi Healthcare Advertising Advertising/Marketing ServicesCommercial Services Part of Publicis Healthcare Communications Group, Inc., Saatchi & Saatchi Healthcare Advertising provides advertising services.	Commercial Services
Myovant Sciences, Inc. Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.	Health Technology
Myovant Sciences Ltd. Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an